Anaphylactic reactions. Not to be inj intravascularly or intradermally. Not for prevention against diseases caused by pathogens other than Corynebacterium diphtheriae
, Clostridium tetani
, Bordetella pertussis
, HBV, poliovirus or HIB. Postpone vaccination in patients w/ acute severe febrile illness. Temp ≥40°C; collapse or shock-like state; persistent, inconsolable crying lasting ≥3 hr occurring w/in 48 hr of vaccination; convulsions w/ or w/o fever occurring w/in 3 days of vaccination. Thrombocytopenia or bleeding disorder; history of febrile convulsions or Sudden Infant Death Syndrome; syncope. Resp monitoring for 48-72 hr in very preterm infants (≤28 wk of gestation) & w/ previous history of resp immaturity. Immunosuppressed patients. Co-administration w/ pneumococcal conjugate vaccine. Defer pertussis immunization in childn w/ progressive neurological disorders.